Effectiveness of needle/syringe programmes and opiate substitution therapy in preventing HCV transmission among people who inject drugs (Protocol)

L. Platt, J. Reed, S. Minozzi, P. Vickerman, H. Hagan, C. French, A. Jordan, L. Degenhardt, V. Hope, S. Hutchinson, L. Maher, N. Palmateer, A. Taylor, M. Hickman

Research output: Contribution to journalArticle

49 Downloads (Pure)

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:
1. To assess the impact of needle/syringe programmes with and without opiate substitution th erapy (OST) on the incidence ofHCV infection among people who inject drugs (PWID).
2. To assess the effect of OST alone on the incidence of HCV infection among PWID.
Original languageEnglish
Article numberCD012021
Journal Cochrane Database of Systematic Reviews
Issue number1
Early online date12 Jan 2016
DOIs
Publication statusPublished - Jan 2016

    Fingerprint

Keywords

  • opiate substitution therapy
  • HCV transmission

Cite this

Platt, L., Reed, J., Minozzi, S., Vickerman, P., Hagan, H., French, C., Jordan, A., Degenhardt, L., Hope, V., Hutchinson, S., Maher, L., Palmateer, N., Taylor, A., & Hickman, M. (2016). Effectiveness of needle/syringe programmes and opiate substitution therapy in preventing HCV transmission among people who inject drugs (Protocol). Cochrane Database of Systematic Reviews , (1), [CD012021]. https://doi.org/10.1002/14651858.CD012021